Adolescent and Young Adult (AYA) Oncology in the United States in 2025: Finding Its Place in the Oncology World-Part 1 of 2.

IF 0.9 4区 医学 Q4 HEMATOLOGY
Peter H Shaw, Sharon M Castellino, Jonathan Metts, Ryan Guerrettaz, Brandon Hayes-Lattin, Hong De Sa, Archie Bleyer
{"title":"Adolescent and Young Adult (AYA) Oncology in the United States in 2025: Finding Its Place in the Oncology World-Part 1 of 2.","authors":"Peter H Shaw, Sharon M Castellino, Jonathan Metts, Ryan Guerrettaz, Brandon Hayes-Lattin, Hong De Sa, Archie Bleyer","doi":"10.1097/MPH.0000000000003067","DOIUrl":null,"url":null,"abstract":"<p><p>In 2015 this core of authors wrote a \"state of the union\" overview of AYA oncology care at the time titled \"Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence.\" Since then, the landscape of cancer care in this unique population has changed, with encouraging improvement in some areas and persistent challenges in others. Nine years later, we have decided to update our review to demonstrate how far we have come in caring for 15 to 39-year olds with cancer in the United States and how much further we need to go to truly improve both their short-term and long-term outcomes. What started as a call to arms after the AYA-specific Progress Review Group (PRG) in 2006 became a national initiative, which has had successes and failures nationally, regionally, and locally in trying to move the needle for a group of patients that continues to straddle both the pediatric and adult oncology worlds. Back in 2015, we described the field as in its late adolescence, still trying to define itself. With this 2-part review, we hope to demonstrate that as a subspecialty it has grown up but is still trying to firmly establish its place in the larger world of oncology, much like a young adult that has moved away from home and is establishing its own identity in a changing world. In part 1 we focus on epidemiology of AYA cancer as well as acute lymphoblastic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and sarcoma in this unique population of patients.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000003067","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In 2015 this core of authors wrote a "state of the union" overview of AYA oncology care at the time titled "Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence." Since then, the landscape of cancer care in this unique population has changed, with encouraging improvement in some areas and persistent challenges in others. Nine years later, we have decided to update our review to demonstrate how far we have come in caring for 15 to 39-year olds with cancer in the United States and how much further we need to go to truly improve both their short-term and long-term outcomes. What started as a call to arms after the AYA-specific Progress Review Group (PRG) in 2006 became a national initiative, which has had successes and failures nationally, regionally, and locally in trying to move the needle for a group of patients that continues to straddle both the pediatric and adult oncology worlds. Back in 2015, we described the field as in its late adolescence, still trying to define itself. With this 2-part review, we hope to demonstrate that as a subspecialty it has grown up but is still trying to firmly establish its place in the larger world of oncology, much like a young adult that has moved away from home and is establishing its own identity in a changing world. In part 1 we focus on epidemiology of AYA cancer as well as acute lymphoblastic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and sarcoma in this unique population of patients.

2025年美国的青少年和年轻成人(AYA)肿瘤学:在肿瘤学领域找到自己的位置(2集之一)。
2015年,这些核心作者撰写了一篇关于AYA肿瘤治疗的“现状”概述,题为“美国青少年和年轻人(AYA)肿瘤学:青春期晚期的专业”。从那时起,这一独特人群的癌症治疗格局发生了变化,在一些领域取得了令人鼓舞的进展,而在其他领域则面临着持续的挑战。9年后,我们决定更新我们的评估,以证明我们在照顾美国15至39岁的癌症患者方面已经走了多远,以及我们需要走多远才能真正改善他们的短期和长期结果。2006年,专门针对aya的进展审查小组(PRG)发起了一项全国性的倡议,在全国、地区和地方都取得了成功和失败,试图为儿科和成人肿瘤领域的一组患者带来改变。早在2015年,我们就将该领域描述为处于青春期后期,仍在努力定义自己。通过这两部分的回顾,我们希望证明,作为一个亚专科,它已经成长起来,但仍在努力牢固地建立自己在更大的肿瘤学世界中的地位,就像一个年轻人离开家,在不断变化的世界中建立自己的身份。在第一部分中,我们将重点介绍AYA癌症的流行病学,以及急性淋巴细胞白血病、霍奇金淋巴瘤、非霍奇金淋巴瘤和肉瘤在这一独特患者群体中的流行病学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
8.30%
发文量
415
审稿时长
2.5 months
期刊介绍: ​Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信